STC-3515

N/A

Report date: 2024/02/06 15:03:32

Base Information

Drug NameSTC-3515

Drug Alias NameSTC-3515

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSerine/threonine-protein kinase WEE1 inhibitorsMembrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase inhibitors

TargetsSerine/threonine-protein kinase WEE1Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSchrodinger Inc

China Registration ClassN/A

Develop Information

Active CompaniesSchrodinger Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A